Home Must Reads Oregon to receive $3.8M settlement from GlaxoSmithKline case

Oregon to receive $3.8M settlement from GlaxoSmithKline case

| Print |  Email
Must Reads
Thursday, June 05, 2014

The state will receive $3.8 million under a multi-state settlement after the drug firm was accused of improperly marketing three pharmaceutical products.

The Oregon Department of Justice and its counterpart in Illinois spearheaded a lawsuit accusing GSK of marketing the drug Advair for mild asthma through 2010, though it had only been approved for moderate to severe cases due to risks of the drug.

The suit also accused the firm of improperly marketing two other drugs between 1999 and 2003. It said the firm deceptively promoted the antidepressant Paxil as safe for children and adolescents when it was not approved, raising concerns of increased suicide risk. It said GSK improperly promoted another antidepressant, Wellbutrin, for weight loss and sexual dysfunction though it was never approved for those things.

Read more at OregonLive.com

 

More Articles

The clean fuels opportunity

News
Monday, November 10, 2014
111014-dirtyfuel-thumbBY KIM MOORE | OB RESEARCH EDITOR

A market for low-carbon transportation fuels has a chance to flourish in Oregon if regulators adopt the second phase of the state’s Clean Fuels Program.


Read more...

Grape Expectations

October 2014
Thursday, September 25, 2014
BY HANNAH WALLACE

Well-financed outsiders from France and California are buying up vineyards and wineries in the Willamette Valley.


Read more...

Political Clout

November/December 2014
Wednesday, October 22, 2014
BY KIM MOORE

Businesses spend billions of dollars each year trying to influence political decision makers by piling money into campaigns.


Read more...

Two Sides of the Coin

Contributed Blogs
Wednesday, October 22, 2014
22 twosidesBY JASON NORRIS

Historically, when the leaves fall, so do the markets. This year, earnings, Europe, energy and Ebola have in common? Beyond alliteration, they are four factors that the investors are pointing to for this year’s seasonal volatility.


Read more...

Election Season

November/December 2014
Wednesday, October 22, 2014

We didn’t intend this issue to have an election season theme. But politics has a way of seeping into the cracks and fissures.


Read more...

October surprise

News
Sunday, October 12, 2014
roundup-logo-thumb-14BY LINDA BAKER

Cylvia Hayes, tabloid vs. watchdog journalism and the looming threat of a Cascadia earthquake.


Read more...

Healthcare pullback

News
Thursday, November 20, 2014
112014-boehnercare-thumbBY JASON NORRIS | OB CONTRIBUTOR

Each month for Oregon Business, we assess factors that are shaping current capital market activity—and what they mean to investors. Here we take a look at two major developments regarding possible rollbacks of the Affordable Care Act (ACA).


Read more...
Oregon Business magazinetitle-sponsored-links-02
SPONSORED LINKS